Source: Virtual Congress 2020 – Monitoring of patients with COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Aksoy (Istanbul, Turkey), S. Dadas (Istanbul, Turkey), B. Yilmaz (Istanbul, Turkey), H. Erten (Istanbul, Turkey), M. Hörmet (Istanbul, Turkey), G. Tomas (Istanbul, Turkey), E. Tuncay (Istanbul, Turkey), S. Güngör (Istanbul, Turkey), Ö. Moçin (Istanbul, Turkey), N. Adigüzel (Istanbul, Turkey), G. Güngör (Istanbul, Turkey), Z. Karakurt (Istanbul, Turkey). Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype. 1045

Member's Comments

No comment yet.

Related content which might interest you: Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease? Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD Source: Virtual Congress 2020 – Investigations of COPD Year: 2020 Genetically elevated C-reactive protein and chronic obstructive pulmonary disease Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD Year: 2009 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Factors affecting C-reactive protein levels in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 A?-Val360: a marker of neutrophil elastase and COPD disease activity Source: Eur Respir J 2013; 41: 31-38 Year: 2013 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020 Clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008